B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CCNC

MOLECULAR TARGET

cyclin C

UniProt: P24863NCBI Gene: 8921 compounds

CCNC (cyclin C) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CCNC

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Sorafenib1.393

About CCNC as a Drug Target

CCNC (cyclin C) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented CCNC interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CCNC inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.